FDA grants tentative OK to Perrigo's generic diabetes med

07/21/2013 | Drug Store News

Perrigo's diabetes drug repaglinide obtained tentative approval from the FDA as a treatment for type 2 diabetes. The drug is a generic copy of Prandin from Novo Nordisk.

View Full Article in:

Drug Store News